These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2755275)

  • 41. Absorption kinetics of cyclosporine in healthy volunteers.
    Gupta SK; Benet LZ
    Biopharm Drug Dispos; 1989; 10(6):591-6. PubMed ID: 2611359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimizing the absorption of valspodar, a P-glycoprotein modulator, Part I: Selecting an oral formulation and exploring its clinical pharmacokinetics/dynamics.
    Mueller EA; Kovarik JM; Uresin Y; Preisig-Flückiger SS; Hensel S; Lücker PW; Holt B
    J Clin Pharmacol; 1997 Nov; 37(11):1001-8. PubMed ID: 9505992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancement of the oral absorption of cyclosporin in man.
    Drewe J; Meier R; Vonderscher J; Kiss D; Posanski U; Kissel T; Gyr K
    Br J Clin Pharmacol; 1992 Jul; 34(1):60-4. PubMed ID: 1633069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tolerance of cyclosporine oral capsules in a patient hypersensitive to standard oral and intravenous solutions of the drug.
    Cooney GF; Alpern JB; Narins BE; Goetz LK; Cavarocchi NC
    Clin Transpl; 1989; ():324. PubMed ID: 2487599
    [No Abstract]   [Full Text] [Related]  

  • 45. Oral absorption of CGS-20625, an insoluble drug, in dogs and man.
    Hirschberg Y; Oberle RL; Ortiz M; Lau H; Markowska M
    J Pharmacokinet Biopharm; 1995 Feb; 23(1):11-23. PubMed ID: 8576841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dosage forms of cyclosporine.
    Yee GC
    Pharmacotherapy; 1991; 11(6):149S-152S. PubMed ID: 1771140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liposomal formulation eliminates acute toxicity and pump incompatibility of parenteral cyclosporine.
    Gruber SA; Venkataram S; Canafax DM; Cipolle RJ; Bowers L; Elsberry D; McGuiggan M; Hynes PE; Ritz JA; Gould FH
    Pharm Res; 1989 Jul; 6(7):601-7. PubMed ID: 2798309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and bioavailability of papaverine HCl following intravenous, peroral, rectal, vaginal, topical and buccal administration in beagle dogs.
    Kraus C; Shaaya A; Ulmer J; Hutchings D; Menon A; Sakr A; Ritschel WA
    Biopharm Drug Dispos; 1991 Oct; 12(7):537-46. PubMed ID: 1932615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bioavailability of cyclandelate from capsules in beagle dogs and dissolution rate: correlations with bioavailability in humans.
    Kaniwa N; Ogata H; Aoyagi N; Ejima A; Takahashi T; Uezono Y; Imasato Y
    J Pharmacobiodyn; 1991 Mar; 14(3):152-60. PubMed ID: 1880705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pharmacokinetics and colonic tissue concentrations of cyclosporine after i.v., oral, and enema administration.
    Sandborn WJ; Strong RM; Forland SC; Chase RE; Cutler RE
    J Clin Pharmacol; 1991 Jan; 31(1):76-80. PubMed ID: 2045532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclosporine pharmacokinetics in cats following topical ocular administration.
    Gregory CR; Hietala SK; Pedersen NC; Gregory TA; Floyd-Hawkins KA; Patz JD
    Transplantation; 1989 Mar; 47(3):516-9. PubMed ID: 2646782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of bile on cyclosporine absorption in dogs.
    Venkataramanan R; Perez HD; Schwinghammer T; Burckart GJ; Ptachcinski RJ; Van Thiel DH; Starzl TE
    Res Commun Chem Pathol Pharmacol; 1986 Jul; 53(1):137-40. PubMed ID: 3749608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of methods to calculate cyclosporine A bioavailability from consecutive oral and intravenous doses.
    Karlsson MO; Lindberg-Freijs A
    J Pharmacokinet Biopharm; 1990 Aug; 18(4):293-311. PubMed ID: 2231321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accuracy and precision of compounded ciclosporin capsules and solution.
    Umstead ME; Boothe DM; Cruz-Espindola C; Macdonald JM; Kennis R; Angarano D
    Vet Dermatol; 2012 Oct; 23(5):431-e82. PubMed ID: 22970897
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of obesity on cyclosporine pharmacokinetics in uremic patients.
    Flechner SM; Kolbeinsson MC; Lum B; Tam J; Moran T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1446-8. PubMed ID: 2652464
    [No Abstract]   [Full Text] [Related]  

  • 56. Bioavailability of intramuscular ciclosporin in the pig.
    Filipponi F; Messori A; Valenza T; Fabbri LP; Falcini F
    Eur Surg Res; 1990; 22(1):14-8. PubMed ID: 2379521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclosporine absorption in two patients with short-bowel syndrome.
    Roberts R; Sketris IS; Abraham I; Givner ML; MacDonald AS
    Drug Intell Clin Pharm; 1988; 22(7-8):570-2. PubMed ID: 3416741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size.
    Tarr BD; Yalkowsky SH
    Pharm Res; 1989 Jan; 6(1):40-3. PubMed ID: 2717516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of two alternative dosage forms for cyclosporine: liposomes and intralipid.
    Venkataram S; Awni WM; Jordan K; Rahman YE
    J Pharm Sci; 1990 Mar; 79(3):216-9. PubMed ID: 2338629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of cyclosporine in the weanling pig.
    Freeman DJ; Lipohar C; Kreeft J; Grant DR
    Transplantation; 1990 Nov; 50(5):892-3. PubMed ID: 2238070
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.